Published in

Oxford University Press, Endocrinology, 7(151), p. 3472-3472, 2010

DOI: 10.1210/endo.151.7.9997

Oxford University Press (OUP), The Journal of Clinical Endocrinology & Metabolism, 9(95), p. E26-E31

DOI: 10.1210/jc.2010-0305

Links

Tools

Export citation

Search in Google Scholar

Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome

Journal article published in 2010 by Ali Abbasi, Eva Corpeleijn ORCID, Douwe Postmus, Ron T. Gansevoort, Rijk O. B. Gans, Paul E. de Jong, Joachim Struck, Hans L. Hillege, Ronald P. Stolk, Gerjan Navis, Stephan J. L. Bakker
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Context: Procalcitonin, a well-known biomarker of sepsis and bacterial infections, is produced by adipose tissue and has potential as a marker for chronic low-grade inflammation. Objectives: The objective of this study was to investigate whether plasma procalcitonin levels in the normal range are associated with obesity, insulin resistance, and metabolic syndrome (MS) in the general population. Methods: Plasma procalcitonin (0.006-0.1 ng/ml) was measured in 3197 men and 3638 women (aged 28-75 yr) of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study using an ultra-sensitive immunoluminometric assay. MS was defined according to Adult Treatment Panel III criteria. Results: Median (interquartile range) plasma procalcitonin was 0.018 (0.015-0.022) ng/ml in men and0.014 (0.012-0.017) ng/ml inwomen(P